Optimal adaptive control of drug dosing using integral reinforcement learning.


Journal

Mathematical biosciences
ISSN: 1879-3134
Titre abrégé: Math Biosci
Pays: United States
ID NLM: 0103146

Informations de publication

Date de publication:
03 2019
Historique:
received: 20 10 2018
revised: 24 01 2019
accepted: 31 01 2019
pubmed: 9 2 2019
medline: 18 12 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

In this paper, a reinforcement learning (RL)-based optimal adaptive control approach is proposed for the continuous infusion of a sedative drug to maintain a required level of sedation. To illustrate the proposed method, we use the common anesthetic drug propofol used in intensive care units (ICUs). The proposed online integral reinforcement learning (IRL) algorithm is designed to provide optimal drug dosing for a given performance measure that iteratively updates the control solution with respect to the pharmacology of the patient while guaranteeing convergence to the optimal solution. Numerical results are presented using 10 simulated patients that demonstrate the efficacy of the proposed IRL-based controller.

Identifiants

pubmed: 30735696
pii: S0025-5564(18)30358-4
doi: 10.1016/j.mbs.2019.01.012
pii:
doi:

Substances chimiques

Anesthetics, Intravenous 0
Propofol YI7VU623SF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-142

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Regina Padmanabhan (R)

Department of Electrical Engineering, Qatar University, Qatar. Electronic address: regina.ajith@qu.edu.qa.

Nader Meskin (N)

Department of Electrical Engineering, Qatar University, Qatar. Electronic address: nader.meskin@qu.edu.qa.

Wassim M Haddad (WM)

School of Aerospace Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0150, USA. Electronic address: wm.haddad@aerospace.gatech.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH